安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Global Biotechnology Company | CSL
CSL Always Evolving for a Better World CSL has delivered biotechnology excellence for over a century Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need
- We Are CSL | CSL
CSL was established in Australia in 1916 to service the health needs of a nation isolated by war Over the ensuing years CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases
- Global Biotechnology Company - CSL
CSL Behring is a global biotherapeutics leader driven by our promise to save lives Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas
- Careers - CSL
CSL offers Promising FUTURES, find yours here CSL was established in Australia in 1916 Over the ensuing years, CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases
- Our Businesses and Products - CSL
For over a century, we’ve been an unstoppable force, from developing medicines that save and improve lives to vaccines that protect them Today, with the combined expertise of CSL Behring (with oversight to CSL Plasma), CSL Seqirus, and CSL Vifor—and our singular commitment to relentlessly innovate—CSL’s offerings are more diverse than ever to help ensure patients and people everywhere
- Our Corporate Profile | Global Biotechnology Company | CSL
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology
- Financial Results and Information | Global Biotechnology Company | CSL
2025 Half Year Financial Results We have announced our 2025 Half Year Financial Results for the period ending 31 st December 2024 Announcement information was released on Tuesday, 11 th February 2025 (AEDT) Please click here to view full information The 2025 Half Year Financial Results Webcast was broadcast live on Tuesday, 11 th February 2025 (AEDT)
- Global plasma collector - CSL
Plasma is a gold-colored liquid that carries red blood cells, white blood cells, and platelets Plasma is made up of water (about 90%), proteins and clotting factors (8%), and small amounts of salts, glucose (blood sugar) and lipids (fats)
|
|
|